More than 10 oral and mini-oral presentations span Pfizer’s extensive Oncology portfolio of approved and investigational therapies
New analyses, including presentations on mavacamten, apixaban and milvexian, further solidify the company's strength and expertise as a leader in cardiovascular diseases
This development will position the company at the forefront of anti- malaria API production globally and is expected to drive substantial growth and profitability
The acquisition will further strengthen Barentz’ position in India creating a leading life science distribution platform
Contepo offers a unique mechanism of action and has the potential to address increasing antibiotic resistance and gaps in the current antibiotic treatment landscape
The agreement has an initial term until March 31, 2029 and no further details on the financial terms of the deal are being disclosed
The joint venture will help JV Partners combine their strengths and grow their complementary nutraceuticals portfolios
Fluid bed processes: drying, granulating, and coating in just one product container
Highly effective preservation solutions ensuring the safety and protection of personal care products
Cipla will be responsible for the distribution of Sanofi India's six CNS brands including Frisium
Subscribe To Our Newsletter & Stay Updated
